Poster Presentation ANZOS-OSSANZ-AOCO Joint Annual Scientific Meeting 2017

Trends of proton pump therapy use post laparoscopic sleeve gastrectomy  (#220)

Sukaina Jaffar 1 , Michael Devadas
  1. Nepean Hospital, Rushcutters Bay, NEW SOUTH WALES, Australia


Functional UGI symptoms after bariatric surgery, especially acid-reflux symptoms are well-reported in literature. What has not been evaluated, is usage of proton pump inhibitors (PPI) after Laparoscopic Sleeve Gastrectomy (LSG). Dysphagia is another clinical entity that is not thoroughly studied post LSG. Furthermore, there is no current evidence correlating PPI therapy with dysphagia post LSG.


To compare prevalence of PPI usage pre and post-operatively in patients that underwent LSG. To assess if self-reported dysphagia affects PPI usage. 


101 consecutive patients that underwent LSG were retrospectively analysed. Contrast studies performed pre-operatively excluded hiatus hernia. Presence of pre-operative GORD and PPI use was recorded. At one year follow-up, all patients completed a clinically validated dysphagia assessment questionnaire.


Overall, pre-operatively 16 of 101 patients were on PPI therapy. At follow up of one year or greater, 20 patients were found to be on PPI which is a significant increase (p=0.01).

Commencement of new PPI therapy within one year post surgery occurred in 13 of 85 patients (15%). Only 7 of 16 patients (44%) continued ongoing PPI usage post-operatively.

Logistic regression analysis revealed the odds of requiring PPIs one year after LSG is 4.3 [95% CI 1.36-13.62] times higher in patients on PPI therapy pre-operatively. Patients on PPI at follow-up also revealed significantly higher dysphagia scores by 2 points (p=0.043).


There was a significant increase in PPI usage 12 or more months after LSG. A correlation between self-reported dysphagia and PPI usage was also found. The factors that contribute to symptoms of reflux need to be further studied to ascertain whether PPI use is indicated in these patients.